HA-RAS POLYMORPHISMS IN EPITHELIAL OVARIAN-CANCER

被引:4
|
作者
OBRIANT, K
CHRYSSON, N
HUNTER, V
TYSON, F
TANNER, M
DALY, L
GEORGE, SL
BERCHUCK, A
SOPER, J
FOWLER, W
CLARKEPEARSON, D
BAST, RC
机构
[1] DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT COMMUNITY & FAMILY MED,DURHAM,NC 27710
[3] DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DURHAM,NC 27710
[4] DUKE COMPREHENS CANC CTR,DURHAM,NC 27710
[5] UNIV N CAROLINA,DEPT OBSTET & GYNECOL,CHAPEL HILL,NC 27514
关键词
D O I
10.1016/0090-8258(92)90308-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Unusual restriction fragment length polymorphisms (RFLPs) of the Ha-ras locus have been found in DNA from leukocytes and tumor tissue of cancer patients. To determine whether rare alleles would be observed frequently in patients with ovarian cancer, Ha-ras RFLPs were studied in DNA from 42 different ovarian epithelial tumors and from the peripheral blood leukocytes of 76 normal individuals. Four common, seven intermediate, and seven rare alleles were detected overall. Similar fractions of rare alleles were found in DNA from ovarian cancers and from the peripheral blood of normal individuals. Thus, the frequency of unusual Ha-ras RFLPs did not distinguish patients with ovarian cancers from apparently healthy individuals. © 1992.
引用
收藏
页码:299 / 302
页数:4
相关论文
共 50 条
  • [21] INVESTIGATIONAL THERAPIES FOR EPITHELIAL OVARIAN-CANCER
    KAVANAGH, JJ
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1985, 28 (04): : 846 - 852
  • [22] LACTATION AND THE RISK OF EPITHELIAL OVARIAN-CANCER
    ROSENBLATT, KA
    THOMAS, DB
    BERRY, G
    MACLENNAN, R
    SHEARMAN, R
    JELIHOVSKY, T
    BOOTH, JC
    MOLINA, R
    MARTINEZ, L
    SALES, O
    DABANCENS, A
    CHEN, ZH
    TAO, Y
    HU, YW
    MODAN, B
    RON, E
    ALFANDARY, E
    CUEVAS, HR
    SALAZAR, SB
    PALET, A
    ONTIVEROS, P
    APELO, RA
    DELACRUZ, JR
    BAENS, J
    JAVIER, B
    PARDTHAISONG, T
    MARTIN, N
    THEETRANONT, C
    BOOSIRI, B
    CHUTIVONGSE, S
    VIRUTAMASEN, P
    WONGSRICHANALAI, C
    JIMAKORN, P
    KOETSAWANG, S
    RACHAWAT, D
    KOETSAWANG, A
    SCULLY, RE
    YOUNG, RH
    THOMAS, DB
    ROSENBLATT, KA
    NOONAN, EA
    HOLCK, S
    FARLEY, T
    MEIRIK, O
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1993, 22 (02) : 192 - 197
  • [23] CHEMOTHERAPY OF EPITHELIAL OVARIAN-CANCER - AN OVERVIEW
    SUTTON, G
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1994, 37 (02): : 461 - 474
  • [24] TAMOXIFEN THERAPY OF EPITHELIAL OVARIAN-CANCER
    SHIREY, DR
    KAVANAGH, JJ
    GERSHENSON, DM
    FREEDMAN, RS
    COPELAND, LJ
    JONES, LA
    OBSTETRICS AND GYNECOLOGY, 1985, 66 (04): : 575 - 578
  • [25] SIDE OF ORIGIN OF EPITHELIAL OVARIAN-CANCER
    LOWRY, WS
    ATKINSON, RJ
    BRITISH MEDICAL JOURNAL, 1992, 304 (6825): : 507 - 507
  • [26] GENETIC EPIDEMIOLOGY OF EPITHELIAL OVARIAN-CANCER
    AMOS, CI
    STRUEWING, JP
    CANCER, 1993, 71 (02) : 566 - 572
  • [27] HUMAN EPITHELIAL OVARIAN-CANCER ALLELOTYPE
    CLIBY, W
    RITLAND, S
    HARTMANN, L
    DODSON, M
    HALLING, KC
    KEENEY, G
    PODRATZ, KC
    JENKINS, RB
    CANCER RESEARCH, 1993, 53 (10) : 2393 - 2398
  • [28] EPITHELIAL OVARIAN-CANCER - CONSENSUS IN 1995
    CHEVALLIER, B
    DESSOGNE, P
    BULLETIN DU CANCER, 1995, 82 (11) : 923 - 928
  • [29] RESEARCH DIRECTIONS IN EPITHELIAL OVARIAN-CANCER
    OZOLS, RF
    GYNECOLOGIC ONCOLOGY, 1994, 55 (03) : S168 - S173
  • [30] SECONDARY CYTOREDUCTION IN EPITHELIAL OVARIAN-CANCER
    MORGAN, MA
    RUBIN, SC
    CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1995, 18 (01) : 1 - 8